eQTL of KCNK2 regionally influences the brain sulcal widening: evidence from 15,597 UK Biobank participants with neuroimaging data.


Journal

Brain structure & function
ISSN: 1863-2661
Titre abrégé: Brain Struct Funct
Pays: Germany
ID NLM: 101282001

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 30 04 2018
accepted: 01 12 2018
pubmed: 7 12 2018
medline: 2 7 2019
entrez: 7 12 2018
Statut: ppublish

Résumé

The grey and white matter volumes are known to reduce with age. This cortical shrinkage is visible on magnetic resonance images and is conveniently identified by the increased volume of cerebrospinal fluid in the sulci between two gyri. Here, we replicated this finding using the UK Biobank dataset and studied the genetic influence on these cortical features of aging. We divided all individuals genetically confirmed of British ancestry into two sub-cohorts (12,162 and 3435 subjects for discovery and replication samples, respectively). We found that the heritability of the sulcal opening ranges from 15 to 45% (SE = 4.8%). We identified 4 new loci that contribute to this opening, including one that also affects the sulci grey matter thickness. We identified the most significant variant (rs864736) on this locus as being an expression quantitative trait locus (eQTL) for the KCNK2 gene. This gene regulates the immune-cell into the central nervous system (CNS) and controls the CNS inflammation, which is implicated in cortical atrophy and cognitive decline. These results expand our knowledge of the genetic contribution to cortical shrinking and promote further investigation into these variants and genes in pathological context such as Alzheimer's disease in which brain shrinkage is a key biomarker.

Identifiants

pubmed: 30519892
doi: 10.1007/s00429-018-1808-9
pii: 10.1007/s00429-018-1808-9
pmc: PMC6420450
doi:

Substances chimiques

Potassium Channels, Tandem Pore Domain 0
potassium channel protein TREK-1 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

847-857

Subventions

Organisme : Medical Research Council
ID : MC_PC_17228
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_QA137853
Pays : United Kingdom
Organisme : H2020 European Research Council
ID : 720270 (HBPSGA1)
Organisme : H2020 European Research Council
ID : 785907 (HBPSGA2)

Références

Cereb Cortex. 1999 Mar;9(2):151-60
pubmed: 10220227
J Neuroimaging. 1999 Oct;9(4):201-9
pubmed: 10540599
Neurology. 2000 Jul 12;55(1):134-6
pubmed: 10891924
Neuroscience. 2001;103(4):899-919
pubmed: 11301200
Neuroimage. 2001 Sep;14(3):685-700
pubmed: 11506541
Neurobiol Aging. 2001 Nov-Dec;22(6):799-809
pubmed: 11754986
AJNR Am J Neuroradiol. 2002 Sep;23(8):1327-33
pubmed: 12223373
Am J Hum Genet. 2004 Apr;74(4):765-9
pubmed: 14997420
Neuroimage. 2004;23 Suppl 1:S129-38
pubmed: 15501082
Cereb Cortex. 2005 Nov;15(11):1676-89
pubmed: 15703252
Top Magn Reson Imaging. 2004 Dec;15(6):369-89
pubmed: 16041289
Hum Brain Mapp. 2005 Nov;26(3):210-20
pubmed: 16161162
Neurosci Biobehav Rev. 2006;30(6):730-48
pubmed: 16919333
Hum Brain Mapp. 2008 Jan;29(1):36-45
pubmed: 17290369
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Neuroradiology. 2007 Dec;49(12):967-76
pubmed: 17955233
Int J Geriatr Psychiatry. 2009 Feb;24(2):109-17
pubmed: 18637641
Magn Reson Imaging. 2009 Oct;27(8):1163-74
pubmed: 19249168
Circ Cardiovasc Genet. 2009 Feb;2(1):73-80
pubmed: 20031568
Neuroimage. 2010 Nov 15;53(3):1126-34
pubmed: 20035879
Bioinformatics. 2010 Sep 15;26(18):2336-7
pubmed: 20634204
Neurobiol Aging. 2012 Mar;33(3):617.e1-9
pubmed: 20739099
Rev Neurosci. 2010;21(3):187-221
pubmed: 20879692
Am J Hum Genet. 2011 Jan 7;88(1):76-82
pubmed: 21167468
Med Image Anal. 2011 Aug;15(4):529-50
pubmed: 21441062
Am J Hum Genet. 2011 May 13;88(5):586-98
pubmed: 21565292
Nat Genet. 2012 Apr 15;44(5):552-61
pubmed: 22504417
Cereb Cortex. 2014 Apr;24(4):1017-29
pubmed: 23236211
Neuroimage. 2013 Dec;83:12-7
pubmed: 23800792
Nat Med. 2013 Sep;19(9):1161-5
pubmed: 23933981
Brain Imaging Behav. 2014 Jun;8(2):153-82
pubmed: 24399358
J Neuroimmune Pharmacol. 2014 Jun;9(3):293-301
pubmed: 24557892
PLoS Genet. 2014 Apr 10;10(4):e1004269
pubmed: 24721987
Neuropsychol Rev. 2014 Sep;24(3):271-89
pubmed: 25146995
Nature. 2015 Apr 9;520(7546):224-9
pubmed: 25607358
Brain Behav Immun. 2015 Aug;48:195-204
pubmed: 25882911
Biomed Res Int. 2015;2015:583931
pubmed: 26346648
Brain. 2016 Apr;139(Pt 4):1252-64
pubmed: 26984188
J Neurochem. 2016 Jul;138(2):265-81
pubmed: 27062641
Cereb Cortex. 2018 Jun 1;28(6):1922-1933
pubmed: 28444225
Nature. 2017 Oct 11;550(7675):204-213
pubmed: 29022597
Neurobiol Learn Mem. 2017 Nov;145:199-204
pubmed: 29042297
Neuroimage. 2018 Feb 1;166:400-424
pubmed: 29079522
Neuroimage. 2018 Feb 1;166:1-9
pubmed: 29080713
Nat Commun. 2017 Nov 28;8(1):1826
pubmed: 29184056
Neurosci Lett. 2018 Apr 3;671:93-98
pubmed: 29438799

Auteurs

Yann Le Guen (Y)

UNATI, Institut Joliot, CEA, Université Paris-Saclay, Neurospin, CEA Saclay, Neurospin Bâtiment 145, 91191, Gif-sur-Yvette Cedex, France. yleguen@stanford.edu.

Cathy Philippe (C)

UNATI, Institut Joliot, CEA, Université Paris-Saclay, Neurospin, CEA Saclay, Neurospin Bâtiment 145, 91191, Gif-sur-Yvette Cedex, France.

Denis Riviere (D)

UNATI, Institut Joliot, CEA, Université Paris-Saclay, Neurospin, CEA Saclay, Neurospin Bâtiment 145, 91191, Gif-sur-Yvette Cedex, France.

Hervé Lemaitre (H)

Institut National de la Santé et de la Recherche Médicale, INSERM Unit 1000 "Neuroimaging and Psychiatry", Faculté de médecine, Université Paris-Sud, Le Kremlin-Bicêtre, France.
Université Paris Descartes, Sorbonne Paris Cité, Paris, France.

Antoine Grigis (A)

UNATI, Institut Joliot, CEA, Université Paris-Saclay, Neurospin, CEA Saclay, Neurospin Bâtiment 145, 91191, Gif-sur-Yvette Cedex, France.

Clara Fischer (C)

UNATI, Institut Joliot, CEA, Université Paris-Saclay, Neurospin, CEA Saclay, Neurospin Bâtiment 145, 91191, Gif-sur-Yvette Cedex, France.

Ghislaine Dehaene-Lambertz (G)

INSERM, UMR992, Institut Joliot, CEA, Université Paris-Saclay, Neurospin, Gif-sur-Yvette, France.

Jean-François Mangin (JF)

UNATI, Institut Joliot, CEA, Université Paris-Saclay, Neurospin, CEA Saclay, Neurospin Bâtiment 145, 91191, Gif-sur-Yvette Cedex, France.

Vincent Frouin (V)

UNATI, Institut Joliot, CEA, Université Paris-Saclay, Neurospin, CEA Saclay, Neurospin Bâtiment 145, 91191, Gif-sur-Yvette Cedex, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH